You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 39 No. 3, March 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Antipsychotic Effects of Pimozide in Schizophrenia

Treatment Response Prediction With Acute Dextroamphetamine Response

Daniel P. van Kammen, MD, PhD; John P. Docherty, MD; Stephen R. Marder, MD; S. Charles Schulz, MD; Lynne Dalton; William E. Bunney, Jr, MD

Arch Gen Psychiatry. 1982;39(3):261-266.


Abstract

• Acute behavioral response to 20 mg of dextroamphetamine (intravenous) predicted fourth-week antipsychotic response to double-blind pimozide treatment. Patients whose psychotic condition improved with dextroamphetamine administration showed more antipsychotic response to pimozide therapy than those whose condition worsened or did not change. Multiple regression analysis indicated amphetamine-induced response predicted pimozide response after four weeks but fifth-week pimozide response was more accurately predicted by prepimozide psychosis ratings. Our study provides some evidence that mechanisms underlying early and late pimozide response are not necessarily identical. Because patients who did not respond to dextroamphetamine administration still improved with pimozide therapy, our data do not support the concept that schizophrenia can be divided into two groups (dopamine-sensitive or dopamine-insensitive) but, rather, that dopamine responsiveness changes over time. Clinical application is not warranted until studies with larger samples have replicated our findings.



Author Affiliations

From the Section on Neuropsychopharmacology, Biological Psychiatry Branch, National Institute of Mental Health (NIMH), Bethesda, Md. Dr Docherty is now with the Psychosocial Research Branch, NIMH, Rockville, Md; Dr Marder is with the Veterans Administration Hospital/Brentwood, Los Angeles; and Dr Schulz is with the Medical College of Virginia, Richmond.


Footnotes

Accepted for publication Sept 21, 1981.

Reprint requests to NIMH, Bldg 10, Room 4N214, Bethesda, MD 20205 (Dr van Kammen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Stimulant psychosis: systematic review
Curran et al.
Br. J. Psychiatry 2004;185:196-204.
ABSTRACT | FULL TEXT  

Long-term Pimozide Pretreatment Differentially Affects Behavioral Responses to Dextroamphetamine in Schizophrenia: Further Exploration of the Dopamine Hypothesis of Schizophrenia
van Kammen et al.
Arch Gen Psychiatry 1982;39:275-281.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.